Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here is What Hedge Funds Think About Barington/Hilco Acquisition Corp. Common Stock (BHAC)

Page 1 of 2

With the third-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the fourth quarter. One of these stocks was Barington/Hilco Acquisition Corp. Common Stock (NASDAQ:BHAC).

Barington/Hilco Acquisition Corp. Common Stock shares haven’t seen a lot of action during the third quarter. Overall, hedge fund sentiment was unchanged. The stock was in 4 hedge funds’ portfolios at the end of the third quarter of 2015. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity, but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as Vringo, Inc. (NASDAQ:VRNG), LRAD Corp (NASDAQ:LRAD), and Palatin Technologies, Inc. (NYSEMKT:PTN) to gather more data points.

Follow Baringtonlco Acquisition Corp. (NASDAQ:BHAC)
Trade (NASDAQ:BHAC) Now!

In the 21st century investor’s toolkit there are tons of metrics stock market investors put to use to assess publicly traded companies. A couple of the most underrated metrics are hedge fund and insider trading moves. We have shown that, historically, those who follow the top picks of the top investment managers can outpace their index-focused peers by a significant amount (see the details here).

Keeping this in mind, we’re going to take a look at the recent action regarding Barington/Hilco Acquisition Corp. Common Stock (NASDAQ:BHAC).

Hedge fund activity in Barington/Hilco Acquisition Corp. Common Stock (NASDAQ:BHAC)

At the end of the third quarter, a total of 4 of the hedge funds tracked by Insider Monkey held long positions in this stock, unchanged from the previous quarter. With the smart money’s sentiment swirling, there exists a few noteworthy hedge fund managers who were boosting their holdings considerably (or already accumulated large positions).

Of the funds tracked by Insider Monkey, Seneca Capital, managed by Douglas Hirsch, holds the most valuable position in Barington/Hilco Acquisition Corp. Common Stock (NASDAQ:BHAC). The fund has a $2.6 million position in the company, comprising 0.9% of its 13F portfolio. Sitting at the No. 2 spot is Andrew Weiss of Weiss Asset Management, with a $2.5 million stake; the fund has 1.9% of its 13F portfolio invested in the stock. Other hedge funds and institutional investors with similar optimism include Paul Glazer’s Glazer Capital and Brian Taylor’s Pine River Capital Management.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!